India IVF Secures $1.25 Million in Pre-Series A Funding from Tomorrow Capital
This investment represents India IVF's first external funding since its inception, following a decade of profitable operations across its 5 North Indian centers which include clinics in Delhi NCR & Srinagar
This new funding will drive India IVF’s expansion across North India, enabling the company to bridge critical gaps in fertility care access
India IVF, one of India’s first tech-enabled pioneering fertility platform founded by Dr. Richika Sahay and Dr. Somendra Shukla in 2014, has secured $1.25 million in pre-Series A funding from Tomorrow Capital, a $100 million venture capital fund dedicated to supporting early-stage, transformative consumer healthcare businesses. This investment represents India IVF's first external funding since its inception, following a decade of profitable operations across its five North Indian centers, which include clinics in Delhi NCR and Srinagar.
This funding will drive India IVF’s expansion across North India, enabling the company to bridge critical gaps in fertility care access. With the goal of making advanced fertility solutions accessible to underserved communities, India IVF has established India’s first tech-enabled fertility platform, offering comprehensive, 360-degree fertility care through advanced technology and a dedicated team of experts. Tomorrow Capital’s investment follows its recent support of VitusCare and IndiShreshtha, further reinforcing its commitment to specialized healthcare ventures.
Rahul Saha, Senior Principal at Tomorrow Capital said, "India IVF has shown remarkable growth and a deep understanding of the unique fertility challenges faced by many Indian couples. With a tech-enabled, patient-focused approach, they deliver high-quality personalized care, addressing the often-emotional & stigma attached journey of the fertility treatment. Tomorrow Capital backs ventures that drive meaningful impact, and with India IVF, we’re proud to enable access to essential fertility care across underserved regions in India. We believe their innovative approach will set new standards in India’s fertility sector, and we are excited to support their mission to make fertility care more accessible across the country."
Dr. Somendra Shukla, Co-Founder & CEO of India IVF, commented, "This partnership will empower us to expand our network and bring advanced fertility solutions to more communities. We look forward to making a positive impact on more families and growing India IVF into a trusted national brand."
Dr. Richika Sahay, Co-Founder & Medical Director, added, "Approximately 30 million couples in India suffer from infertility, yet only 10% receive proper treatment due to limited access to fertility care. Our mission is to leverage technology and innovation to deliver quality, affordable, and empathetic fertility care to everyone. With Tomorrow Capital's support, we are well-positioned to expand access to fertility care across North India."
With Tomorrow Capital’s backing, India IVF is positioned to transform fertility care accessibility in India. By expanding its reach into underrepresented regions and harnessing technology to deliver patient-centered care, India IVF is set to redefine standards in the country’s fertility landscape, supporting couples across North India on their paths to parenthood.